Vaxart VXRT
OTC VXRT
$0.42 -0.02 (-4.55%)
At close: Oct 23, 2026 · 4:00 PM EDT

Vaxart (VXRT) Selling, General & Administrative (2010 - 2026)

Updated

Vaxart (VXRT) recorded Selling, General & Administrative of $6.6 million in Q2 2026, up 43.6% from $4.6 million a year earlier and up 42.3% from the prior quarter.

Analysis

Vaxart (VXRT) Selling, General & Administrative (2010 - 2026) Analysis & Trends

On a TTM basis, Vaxart's Selling, General & Administrative came in at $19.19 million as of Jun 30, 2026, up 6.4% year-over-year; for FY2025, it was $17.61 million, down 15.3% from FY2024.

  • Annual Selling, General & Administrative has declined for three straight years, though with a five-year compound annual growth rate of 3.0% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $20.78 million in FY2024 (-8.0%), $22.58 million in FY2023 (-23.1%), $29.39 million in FY2022 (+34.2%) and $21.89 million in FY2021 (+44.0%).
  • The Q2 2026 figure is the highest quarterly Selling, General & Administrative since Q1 2024.
  • On a year-over-year basis, Selling, General & Administrative rose in 1 of the last eight quarters, with an average decline of 6.8%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 81.0% in Q2 2022, against a decline of 39.9% in Q2 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $4.64 million (Q1 2026), $3.67 million (Q4 2025) and $4.28 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 6.29 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 3.63 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 5.65 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.92 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 3.41 Bn
10 Vaxart 101.99 Mn 37.99 Mn - 6.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.60 Mn
Mar 31, 2026 4.64 Mn
Dec 31, 2025 3.67 Mn
Sep 30, 2025 4.28 Mn
Jun 30, 2025 4.60 Mn
Mar 31, 2025 5.07 Mn
Dec 31, 2024 4.02 Mn
Sep 30, 2024 4.34 Mn
Jun 30, 2024 5.18 Mn
Mar 31, 2024 7.24 Mn
Dec 31, 2023 5.44 Mn
Sep 30, 2023 4.92 Mn
Jun 30, 2023 5.60 Mn
Mar 31, 2023 6.63 Mn
Dec 31, 2022 6.45 Mn
Sep 30, 2022 6.96 Mn
Jun 30, 2022 9.32 Mn
Mar 31, 2022 6.66 Mn
Dec 31, 2021 5.75 Mn
Sep 30, 2021 5.04 Mn
API Access

Vaxart Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VXRT&period=max&api_key=YOUR_API_KEY